Immune checkpoint inhibitors-associated myocarditis without cardiovascular symptoms
Eur J Cancer
.
2023 Nov:194:113319.
doi: 10.1016/j.ejca.2023.113319.
Epub 2023 Oct 2.
Authors
Jonathan Abitbol
1
,
Anais Vallet
2
,
Emilie Routier
2
,
Sondes Smaali
3
,
Caroline Robert
4
Affiliations
1
Dermatology Unit, Department of Oncology, Institut Gustave Roussy, 94805 Villejuif, France; Sorbonne University, 75006 Paris, France.
2
Dermatology Unit, Department of Oncology, Institut Gustave Roussy, 94805 Villejuif, France.
3
Department of Cardiology, Hôpital Marie Lannelongue, 92350 Le Plessis-Robinson, France.
4
Dermatology Unit, Department of Oncology, Institut Gustave Roussy, 94805 Villejuif, France; Paris-Saclay University, 94270 Kremlin Bicêtre, France. Electronic address: caroline.robert@gustaveroussy.fr.
PMID:
37793215
DOI:
10.1016/j.ejca.2023.113319
No abstract available
Publication types
Letter
MeSH terms
Heart Diseases*
Humans
Immune Checkpoint Inhibitors / adverse effects
Myocarditis* / diagnosis
Neoplasms* / drug therapy
Vascular Diseases*
Substances
Immune Checkpoint Inhibitors